Literature DB >> 1673727

Allele loss at the retinoblastoma locus in human ovarian cancer.

S B Li1, P E Schwartz, W H Lee, T L Yang-Feng.   

Abstract

To gain a broad spectrum on allelic loss of specific loci in ovarian tumors, we initially examined DNA from 23 pairs of ovarian tumors and matched peripheral blood lymphocyte samples from the same patients, using 27 polymorphic DNA markers distributed on 13 chromosomes. Significant high frequency of allelic deletion (22%-44%) at chromosome 13 loci (D13S31, D13S32, D13S33, and D13S34) at bands q12-q34 was observed in tumor tissues. These results led us to investigate the loss of heterozygosity at the retinoblastoma (RB) locus in ovarian tumors, because the RB gene is a tumor-suppressor gene located at 13q14. Analysis of the variable number of tandem repeat sequence polymorphism in intron 20 in the RB gene revealed that 6 (30%) of 20 patients with informative samples showed allelic loss at the RB locus in their tumor tissues. This loss, of relatively high frequency, suggests that the RB gene, or a closely linked gene, seems to be involved in the development of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673727     DOI: 10.1093/jnci/83.9.637

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  A de novo satellited short arm of the Y chromosome possibly resulting from an unstable translocation.

Authors:  C L Lin; L Gibson; B Pober; T L Yang-Feng
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

2.  Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.

Authors:  K Yun; M Fukumoto; Y Jinno
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

3.  Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.

Authors:  A P M Jongsma; J M J Piek; R P Zweemer; R H M Verheijen; J W T Klein Gebbinck; G J van Kamp; I J Jacobs; P Shaw; P J van Diest; P Kenemans
Journal:  Mol Pathol       Date:  2002-10

4.  Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.

Authors:  Ellen L Goode; Brooke L Fridley; Robert A Vierkant; Julie M Cunningham; Catherine M Phelan; Stephanie Anderson; David N Rider; Kristin L White; V Shane Pankratz; Honglin Song; Estrid Hogdall; Susanne K Kjaer; Alice S Whittemore; Richard DiCioccio; Susan J Ramus; Simon A Gayther; Joellen M Schildkraut; Paul P D Pharaoh; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

5.  Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.

Authors:  A Viel; F Giannini; L Tumiotto; F Sopracordevole; M C Visentin; M Boiocchi
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

6.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

7.  Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

Authors:  H Gabra; L Taylor; B B Cohen; A Lessels; D M Eccles; R C Leonard; J F Smyth; C M Steel
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

8.  Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.

Authors:  M Fujita; T Enomoto; M Inoue; O Tanizawa; M Ozaki; J M Rice; T Nomura
Journal:  Jpn J Cancer Res       Date:  1994-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.